Retrieve available abstracts of 162 articles: HTML format
Single Articles
July 2025
CRIFASE C, Parker J, Zhang L, Shang S, et al Is cone length a risk factor for internal margin positivity in high-grade
squamous intraepithelial lesions based on age?
Int J Gynecol Cancer. 2025;35:101825. PubMedAbstract available
HSIAO KY, Lin HL, Chen HM, Chen CC, et al Accuracy of human papillomavirus testing using self-collected urine samples for
detecting high-grade squamous intra-epithelial lesion or worse: a diagnostic
meta-analysis.
Int J Gynecol Cancer. 2025;35:101904. PubMedAbstract available
June 2025
BOGANI G, Scambia G, Malzoni M, Casarin J, et al Erratum to 'Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for
fertility-sparing approach: an analysis of the ETERNITY project' [International
Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101643].
Int J Gynecol Cancer. 2025 Jun 5:101960. doi: 10.1016/j.ijgc.2025.101960. PubMed
May 2025
KIM YJ, Yoo YJ, Jang JY, Kim YM, et al Follow-up strategies for patients with cervical cancer who achieved complete
response after definitive chemoradiotherapy.
Int J Gynecol Cancer. 2025 May 21:101933. doi: 10.1016/j.ijgc.2025.101933. PubMedAbstract available
LI J, Cai M, Xie C, Ding S, et al Survival outcomes and safety of nimotuzumab combined with radiotherapy +/-
chemotherapy for locally advanced cervical cancer.
Int J Gynecol Cancer. 2025;35:101930. PubMedAbstract available
MEI X, Fobian SF, IJff M, Crezee J, et al High human papillomavirus viral load and local immune dysregulation are
associated with poor clinical outcomes in patients with cervical cancer.
Int J Gynecol Cancer. 2025;35:101924. PubMedAbstract available
GUERRA RA, Tucker LY, Littell R, Kay AH, et al Long-term impact of surgical route and tumor size on risk of recurrence among
early-stage cervical cancer patients in a managed care population.
Int J Gynecol Cancer. 2025 May 10:101928. doi: 10.1016/j.ijgc.2025.101928. PubMedAbstract available
DOSTALEK L, Brynda D, Marek R, Hederlingova J, et al Regression of high-grade squamous intraepithelial cervical lesions and associated
risk factors (RECER).
Int J Gynecol Cancer. 2025;35:101768. PubMedAbstract available
April 2025
FRENEL JS, Roynard T, Loaec C, Ray-Coquard I, et al Pocket guide based on the TNM and FIGO staging systems for classifying patients
with locally advanced cervical cancer: a practical tool from the GINECO group for
quick and easy management.
Int J Gynecol Cancer. 2025;35:101908. PubMed
FALLAH PN, Salcedo MP, Nhacule E, Utui Y, et al A randomized clinical trial to assess the effectiveness of thermal ablation
versus loop electrosurgical excision procedure for cervical cancer risk reduction
in women living with HIV in Mozambique.
Int J Gynecol Cancer. 2025 Apr 26:101905. doi: 10.1016/j.ijgc.2025.101905. PubMedAbstract available
ZEEVI G, Eitan R The art of prevention: merging creativity and medicine to transform cervical
cancer awareness.
Int J Gynecol Cancer. 2025;35:101909. PubMed
KACPERCZYK-BARTNIK J, El Hajj H, Toth I, Bizzarri N, et al Declaration on cervical cancer elimination: literature review and perspectives
from early-career clinicians.
Int J Gynecol Cancer. 2025;35:101902. PubMedAbstract available
NAVARRO AS, Ricotta G, Gauroy E, Martinez A, et al Urinary reconstruction using enterocystoplasty after partial cystectomy in
surgical recurrence of cervical cancer.
Int J Gynecol Cancer. 2025;35:101813. PubMed
HEMIDA R, Barakat R, Nabil H, Hasan M, et al Cervical cancer elimination in low-resource countries: low-cost strategy.
Int J Gynecol Cancer. 2025 Apr 11:101828. doi: 10.1016/j.ijgc.2025.101828. PubMed
LEE J, Lin JB, Wang CH, Lin WH, et al Whole-uterine versus individualized-uterine radiotherapy in locally advanced
cervical cancer: clinical outcome and toxicity.
Int J Gynecol Cancer. 2025;35:101817. PubMedAbstract available
FALLAH PN, Citonje-Msadabwe S, Fundafunda S, Schmeler KM, et al Scale-up of cervical cancer prevention services in Zambia.
Int J Gynecol Cancer. 2025;35:101816. PubMed
BIZZARRI N, Querleu D, Ramirez PT, Plante M, et al Minimally invasive simple hysterectomy in low-risk cervical cancer: a single-arm
trial with stopping rules (ENGOT-cx23/MITO/LASH trial).
Int J Gynecol Cancer. 2025;35:101818. PubMedAbstract available
LOU J, Li Y, Li R, Guo Y, et al Association between magnetic resonance imaging-measured bone marrow cellularity
and clinical outcomes among patients with cervical cancer treated with programmed
cell death protein-1 inhibitors.
Int J Gynecol Cancer. 2025;35:101808. PubMedAbstract available
TESFAI FM, Yongue G, Chandrasekaran D, Francis N, et al Methods of surgical quality assurance in cervical and endometrial cancer trials:
a systematic review and meta-analysis.
Int J Gynecol Cancer. 2025;35:100018. PubMedAbstract available
March 2025
HUANG Y, Yoh K, Szamreta EA, Xu X, et al Patterns of pembrolizumab use for recurrent cervical cancer.
Int J Gynecol Cancer. 2025;35:101802. PubMedAbstract available
PAVONE M, Baby B, Carles E, Innocenzi C, et al Critical view of safety assessment in sentinel node dissection for endometrial
and cervical cancer: artificial intelligence to enhance surgical safety and lymph
node detection (LYSE study).
Int J Gynecol Cancer. 2025;35:101789. PubMedAbstract available
MORICE P, Gouy S, Plante M, Abu-Rustum N, et al Neoadjuvant chemotherapy in stage IB2 to IB3 cervical cancer: because we can or
because we must?
Int J Gynecol Cancer. 2025 Mar 14:101770. doi: 10.1016/j.ijgc.2025.101770. PubMed
LIAO J, Xu T, Zhou J, Xiao N, et al The impact of chemotherapy on survival in patients aged >/=65 years with
locoregionally cervical cancer who undergo radiotherapy: a Surveillance,
Epidemiology, and End Results database analysis.
Int J Gynecol Cancer. 2025 Mar 3:101747. doi: 10.1016/j.ijgc.2025.101747. PubMedAbstract available
SALVO G, Meyer LA, Gonzales NR, Frumovitz M, et al Neuroendocrine cervical carcinomas: genomic insights, controversies in treatment
strategies, and future directions: a NeCTuR study.
Int J Gynecol Cancer. 2025;35:101639. PubMedAbstract available
DE VITIS LA, Schivardi G, Gaeta A, Caruso G, et al External validation of the annual recurrence risk model for tailored surveillance
strategy in patients with cervical cancer.
Int J Gynecol Cancer. 2025 Mar 1:101756. doi: 10.1016/j.ijgc.2025.101756. PubMedAbstract available
COLLIER E, Soberanis Pina P, McMullen M, Gonzalez-Ochoa E, et al Circulating human papillomavirus DNA sequencing as a biomarker of response in
advanced cervical cancer.
Int J Gynecol Cancer. 2025 Mar 1:101755. doi: 10.1016/j.ijgc.2025.101755. PubMedAbstract available
February 2025
LEITAO MM JR, Bixel KL, Chase DM, Quick A, et al ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for
early-stage cervical cancer.
Int J Gynecol Cancer. 2025 Feb 28:101760. doi: 10.1016/j.ijgc.2025.101760. PubMedAbstract available
BIZZARRI N, Guidi G, Pavone M, Pedone Anchora L, et al Laparoscopic para-uterine lymphovascular tissue sentinel lymph node biopsy with
indocyanine green in cervical cancer.
Int J Gynecol Cancer. 2025 Feb 27:101744. doi: 10.1016/j.ijgc.2025.101744. PubMed
MANZOUR N, Chiva L, Zanagnolo V, Capilna ME, et al SUCCOR 10 years: a decade's perspective on radical hysterectomy outcomes in
cervical cancer.
Int J Gynecol Cancer. 2025 Feb 6:101690. doi: 10.1016/j.ijgc.2025.101690. PubMedAbstract available
YARZA R, Kountouri M, Guedes H, O'Gorman C, et al Progression-free survival as a potential surrogate end point for overall survival
in advanced cervical carcinoma.
Int J Gynecol Cancer. 2025;35:100012. PubMedAbstract available
MILLER KM, Liu C, Zhou Q, Iasonos A, et al RELEVANT-C study: patient-reported prevalence of lower extremity lymphedema after
sentinel lymph node mapping vs lymphadenectomy after surgery for early-stage
cervical cancer.
Int J Gynecol Cancer. 2025;35:100063. PubMedAbstract available
TSIBULAK I, Collins A, Hsu HC, Chacon E, et al Global survey on training and practice in sentinel lymph node mapping for
endometrial and cervical cancer among early-career gynecologic oncologists.
Int J Gynecol Cancer. 2025;35:100050. PubMedAbstract available
DITTO A, Dri M, Leone Roberti Maggiore U, Raspagliesi F, et al Reply to "Correspondence on 'Fertility-sparing treatment with conization versus
radical hysterectomy in patients with early-stage cervical cancer: Inverse
propensity score-weighted analysis,' by Ditto et al" by Phillippe Morice and
Sebastien Gouy.
Int J Gynecol Cancer. 2025;35:100026. PubMed
MATSUO K, Agarwal J, Chen L, Pino C, et al Modified radical hysterectomy for stage IB1 (=2 cm) cervical cancer: assessment
of temporal trends and oncologic outcomes in the United States.
Int J Gynecol Cancer. 2025 Feb 1:101676. doi: 10.1016/j.ijgc.2025.101676. PubMedAbstract available
January 2025
LIEN CJ, Lien WC Wunderlich syndrome as a presenting symptom in cervical cancer.
Int J Gynecol Cancer. 2025 Jan 30:101675. doi: 10.1016/j.ijgc.2025.101675. PubMed
LIMA WAL, Gouveia MC, Oliveira LCM, Scaranti M, et al Revolutionizing first-line cervical cancer treatment: bevacizumab, immunotherapy,
and emerging insights.
Int J Gynecol Cancer. 2025 Jan 28:101661. doi: 10.1016/j.ijgc.2025.101661. PubMed
GUIDI G, Vargiu V, Ammar S, Bizzarri N, et al Radical hysterectomy and ovarian transposition during cesarean section for newly
diagnosed cervical cancer in pregnancy.
Int J Gynecol Cancer. 2025 Jan 25:101663. doi: 10.1016/j.ijgc.2025.101663. PubMed
BOGANI G, Scambia G, Malzoni M, Casarin J, et al Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for
fertilItY-sparing approach: an analysis of the ETERNITY project.
Int J Gynecol Cancer. 2025 Jan 17:101643. doi: 10.1016/j.ijgc.2025.101643. PubMedAbstract available
LEETANAPORN K, Hanprasertpong J Addition of chemotherapy to radiation is associated with improved survival in
older patients with cervical cancer: a Surveillance, Epidemiology, and End
Results database analysis.
Int J Gynecol Cancer. 2025 Jan 9:101633. doi: 10.1016/j.ijgc.2025.101633. PubMedAbstract available
VILLEGAS SANCHEZ S, Ramirez Cantillo S, Hernandez Aramburo PM, Hernandez JM, et al Cervical cancer prevention in Colombian indigenous communities, a project by
Acacia de Vida Foundation.
Int J Gynecol Cancer. 2025 Jan 9:101623. doi: 10.1016/j.ijgc.2024.101623. PubMed
SAHLI L, Siegenthaler F, Buchi CA, Hofer S, et al Role of pre-sacral sentinel lymph nodes in endometrium and cervical cancer:
experience with minimally invasive indocyanine green sentinel lymph node mapping.
Int J Gynecol Cancer. 2025;35:100032. PubMedAbstract available
MORICE P, Gouy S Correspondence on "Fertility-sparing treatment with conization versus radical
hysterectomy in patients with early-stage cervical cancer: inverse propensity
score weighted analysis," by Ditto et al.
Int J Gynecol Cancer. 2025;35:100028. PubMed
AFROZE L, Rahman MS Men's role in women's health: Engaging male partners in cervical cancer
prevention efforts in low-to-middle-income countries.
Int J Gynecol Cancer. 2025;35:100021. PubMed
PRETI M, Lewis F, Carcopino X, Bevilacqua F, et al Vulvar inspection at the time of cervical cancer screening: European Society of
Gynaecological Oncology (ESGO), International Society for the Study of
Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease
(ECSVD), and European
Int J Gynecol Cancer. 2025;35:100007. PubMedAbstract available
RAMIREZ PT Minimally invasive surgery for simple hysterectomy in early-stage cervical
cancer: 'SHAPing' a path forward.
Int J Gynecol Cancer. 2025;35:101619. PubMed
ANAKWENZE C, Kalra A, Lumley C, Chinniah G, et al Cervical cancer stage distribution and survival outcomes in Africa: a systematic
review and meta-analysis.
Int J Gynecol Cancer. 2025;35:100008. PubMedAbstract available
PLANTE M, Mahner S, Sebastianelli A, Bessette P, et al Minimally invasive compared to open surgery in patients with low-risk cervical
cancer following simple hysterectomy: An exploratory analysis from the
Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.
Int J Gynecol Cancer. 2025;35:100001. PubMedAbstract available
December 2024
ALVARENGA-BEZERRA V, Santia MC, Meschini T, Deavers M, et al Challenges in differentiating between primary cervical cancer versus stage II
endometrial cancer.
Int J Gynecol Cancer. 2024;34:1976-1979. PubMed
NASIOUDIS D, Latif NA, Gysler S, Giuntoli RL 2nd, et al Premature adoption of adjuvant chemotherapy for locally advanced cervical
carcinoma before the OUTBACK trial: cautionary tale on outcomes.
Int J Gynecol Cancer. 2024;34:1874-1880. PubMedAbstract available
LINDEGAARD JC, Petric P, Tan LT, Hoskin P, et al Are we making progress in curing advanced cervical cancer-again?
Int J Gynecol Cancer. 2024;34:1940-1945. PubMedAbstract available
GOLIA D'AUGE T, Caruso G, Laudani ME, Nazzaro L, et al Para-aortic lymph node recurrence in surgically treated early-stage cervical
cancer without para-aortic lymph node surgical staging.
Int J Gynecol Cancer. 2024;34:1867-1873. PubMedAbstract available
PAN TL, Pareja R, Chiva L, Rodriguez J, et al Accuracy of pre-operative tumor size assessment compared to final pathology and
frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical
cancer.
Int J Gynecol Cancer. 2024;34:1861-1866. PubMedAbstract available
November 2024
MORETTI-MARQUES R, Alvarenga-Bezerra V, de Cillo PE, Akaishi DY, et al First robotic radical trachelectomy for cervical cancer using the Hugo RAS
platform.
Int J Gynecol Cancer. 2024 Nov 13:ijgc-2024-005895. PubMed
MEKURIA SF, Biazin H, Abebe T, Borgfeldt C, et al Comparing visual inspection with acetic acid, with and without Lugol's Iodine for
triage of HPV self-sample positive women in Ethiopia: a randomized controlled
trial.
Int J Gynecol Cancer. 2024;34:1691-1697. PubMedAbstract available
CHEN M, Han L, Wang Y, Chen Y, et al Association between Silva pattern-based classification and endocervical
adenocarcinoma: a systematic review and meta-analysis.
Int J Gynecol Cancer. 2024;34:1704-1710. PubMedAbstract available
BIZZARRI N, Abu-Rustum NR, Plante M, Ramirez PT, et al Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set
up for the LASH trial.
Int J Gynecol Cancer. 2024;34:1805-1808. PubMedAbstract available
CHEN M, Han L, Wang Y, Chen Y, et al Association between Silva pattern-based classification and endocervical
adenocarcinoma: a systematic review and meta-analysis.
Int J Gynecol Cancer. 2024;34:1704-1710. PubMedAbstract available
CHAMBULE S, Rangeiro R, Batman S, Lathrop E, et al Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical
excision procedure (LEEP) specimens.
Int J Gynecol Cancer. 2024;34:1698-1703. PubMedAbstract available
MEKURIA SF, Biazin H, Abebe T, Borgfeldt C, et al Comparing visual inspection with acetic acid, with and without Lugol's Iodine for
triage of HPV self-sample positive women in Ethiopia: a randomized controlled
trial.
Int J Gynecol Cancer. 2024;34:1691-1697. PubMedAbstract available
October 2024
PAN TL, Pareja R, Chiva L, Rodriguez J, et al Accuracy of pre-operative tumor size assessment compared to final pathology and
frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical
cancer.
Int J Gynecol Cancer. 2024 Oct 23:ijgc-2024-005986. PubMedAbstract available
AFROZE L, Rahman MS Community-based interventions to reduce cervical cancer in low- and middle-income
countries: a call to action.
Int J Gynecol Cancer. 2024 Oct 21:ijgc-2024-006188. PubMed
GOLIA D'AUGE T, Caruso G, Laudani ME, Nazzaro L, et al Para-aortic lymph node recurrence in surgically treated early-stage cervical
cancer without para-aortic lymph node surgical staging.
Int J Gynecol Cancer. 2024 Oct 8:ijgc-2024-005950. doi: 10.1136/ijgc-2024-005950 PubMedAbstract available
GOUVEIA MC, Graziano LM, Leis LV, Scaranti M, et al The evolving landscape of locally advanced cervical cancer treatment.
Int J Gynecol Cancer. 2024 Oct 7:ijgc-2024-006128. doi: 10.1136/ijgc-2024-006128 PubMed
SILVA FILHO ALD, Reis Romualdo G, Pinhati MES, Neves GL, et al Exploring cervical cancer mortality in Brazil: an ecological study on
socioeconomic and healthcare factors.
Int J Gynecol Cancer. 2024 Oct 4:ijgc-2024-005738. doi: 10.1136/ijgc-2024-005738 PubMedAbstract available
GAO H, Wu H, Zhang Y, Li X, et al Long-term survival in patients with para-aortic metastatic cervical cancer
receiving simultaneous integrated boost chemoradiation to positive lymph nodes: a
single-center experience.
Int J Gynecol Cancer. 2024;34:1536-1546. PubMedAbstract available
September 2024
CHAMBULE S, Rangeiro R, Batman S, Lathrop E, et al Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical
excision procedure (LEEP) specimens.
Int J Gynecol Cancer. 2024 Sep 25:ijgc-2024-005827. PubMedAbstract available
DITTO A, Martinelli F, Dri M, Maggiore ULR, et al Fertility-sparing treatment with conization versus radical hysterectomy in
patients with early-stage cervical cancer: inverse propensity score weighted
analysis.
Int J Gynecol Cancer. 2024 Sep 23:ijgc-2024-005418. PubMedAbstract available
EL HAJJ H, Hemida R, Taumberger N, Friko I, et al Advancing cervical cancer prevention in Africa: ESGO's strategic initiatives and
collaborative efforts.
Int J Gynecol Cancer. 2024 Sep 18:ijgc-2024-006059. PubMed
MANNING-GEIST BL, Mueller JJ Raising the bar on collaborative science: the SENECA study and sentinel lymph
node mapping.
Int J Gynecol Cancer. 2024;34:1322-1323. PubMed
ZHANG L, Zhang X, Sui L, Cong Q, et al Risk factors for vaginal squamous intra-epithelial lesions in women with
high-grade cervical lesions.
Int J Gynecol Cancer. 2024;34:1344-1348. PubMedAbstract available
GUO XM, Roman LD, Matsuo K Considerations for route of hysterectomy in low-risk cervical cancer.
Int J Gynecol Cancer. 2024;34:1481. PubMed
MATSUO K, Shimada M, Matsuzaki S, Machida H, et al Assessment of postoperative therapy de-escalation for early-stage,
intermediate-risk cervical cancer.
Int J Gynecol Cancer. 2024;34:1349-1358. PubMedAbstract available
August 2024
BIZZARRI N, Abu-Rustum NR, Plante M, Ramirez PT, et al Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set
up for the LASH trial.
Int J Gynecol Cancer. 2024 Aug 28:ijgc-2024-005941. PubMedAbstract available
GAO H, Wu H, Zhang Y, Li X, et al Long-term survival in patients with para-aortic metastatic cervical cancer
receiving simultaneous integrated boost chemoradiation to positive lymph nodes: a
single-center experience.
Int J Gynecol Cancer. 2024 Aug 28:ijgc-2024-005664. PubMedAbstract available
CARUSO G, Wagar MK, Hsu HC, Hoegl J, et al Cervical cancer: a new era.
Int J Gynecol Cancer. 2024 Aug 7:ijgc-2024-005579. doi: 10.1136/ijgc-2024-005579 PubMedAbstract available
ZAMBRANO HARVEY AR, Galvis-Catano LM, Bonilla-Escobar FJ, Zapata Izquierdo MA, et al Intercultural dialogues and multilevel strategies for cervical cancer prevention
for the Arhuacos indigenous community in Colombia.
Int J Gynecol Cancer. 2024 Aug 7:ijgc-2024-005871. doi: 10.1136/ijgc-2024-005871 PubMed
MATSUO K, Shimada M, Matsuzaki S, Machida H, et al Assessment of postoperative therapy de-escalation for early-stage,
intermediate-risk cervical cancer.
Int J Gynecol Cancer. 2024 Aug 6:ijgc-2024-005597. doi: 10.1136/ijgc-2024-005597 PubMedAbstract available
PEREZ VILLENA JF, Sanchez Salcedo M, Montoya Guivin A, Villoslada Terrones V, et al First workshop on cervix cancer surgery in Latin America: a hands-on experience
from Lima, Peru.
Int J Gynecol Cancer. 2024;34:1294-1295. PubMed
SALANI R, McCormack M, Kim YM, Ghamande S, et al A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab
plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer
(SKYSCRAPER-04).
Int J Gynecol Cancer. 2024;34:1140-1148. PubMedAbstract available
July 2024
LEE ST, Lee YL, Chung CH, Chien WC, et al Cervical cancer and risk of dementia: real-world insights from a nationwide
cohort study in Taiwan.
Int J Gynecol Cancer. 2024 Jul 23:ijgc-2024-005408. PubMedAbstract available
LINDEGAARD JC, Petric P, Tan LT, Hoskin P, et al Are we making progress in curing advanced cervical cancer-again?
Int J Gynecol Cancer. 2024 Jul 10:ijgc-2024-005572. PubMedAbstract available
VAN DEN BERG MC, Berg HF, Stokowy T, Hoivik EA, et al Expression patterns of mismatch repair proteins in cervical cancer uncover
independent prognostic value of MSH-2.
Int J Gynecol Cancer. 2024;34:993-1000. PubMedAbstract available
FRUHAUF F, Cibula D, Kocian R, Zikan M, et al Diagnostic performance of ultrasonography in pre-operative assessment of lymph
nodes in patients with cervical cancer.
Int J Gynecol Cancer. 2024;34:985-992. PubMedAbstract available
June 2024
AKYILDIZ A, Gultekin M, Yigit E, Demir E, et al Efficacy of cumulative cisplatin dose on survival in patients with locally
advanced cervical cancer treated with definitive chemoradiotherapy: multicenter
study by Turkish Oncology Group.
Int J Gynecol Cancer. 2024 Jun 30:ijgc-2024-005419. PubMedAbstract available
AGUSTI N, Viveros-Carreno D, Melamed A, Pareja R, et al Adjuvant external beam radiotherapy combined with brachytherapy for
intermediate-risk cervical cancer.
Int J Gynecol Cancer. 2024 Jun 25:ijgc-2024-005570. PubMedAbstract available
GUO XM, Roman LD, Matsuo K Considerations for route of hysterectomy in low-risk cervical cancer.
Int J Gynecol Cancer. 2024 Jun 23:ijgc-2024-005745. PubMed
SALANI R, McCormack M, Kim YM, Ghamande S, et al A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab
plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer
(SKYSCRAPER-04).
Int J Gynecol Cancer. 2024 Jun 10:ijgc-2024-005588. PubMedAbstract available
DIGGS A, Huang Y, Melamed A, Szamreta E, et al Patterns of use of primary and first-line chemotherapy for recurrence among
patients with cervical cancer.
Int J Gynecol Cancer. 2024 Jun 8:ijgc-2023-004860. doi: 10.1136/ijgc-2023-004860 PubMedAbstract available
PAREJA R Vaginal radical trachelectomy: is now the end of an era?
Int J Gynecol Cancer. 2024;34:806-807. PubMed
May 2024
NISTOR SI, El Tawab S, Zouridis A, Ferrari F, et al Minimally invasive surgery in the management of early stage cervical cancer after
the publication of SHAPE trial.
Int J Gynecol Cancer. 2024 May 31:ijgc-2024-005724. PubMed
April 2024
SHI V, Grover S, Huang Y, Thaker PH, et al Accuracy of surveillance serum squamous cell carcinoma antigen for cervical
cancer recurrence after definitive chemoradiation.
Int J Gynecol Cancer. 2024 Apr 29:ijgc-2024-005303. PubMedAbstract available
CHARNALIA M, Chopra S, Mulani J, Popat P, et al RECIST 1.1 versus clinico-radiological response assessment for locally advanced
cervical cancer: implications on interpreting survival outcomes of future trials.
Int J Gynecol Cancer. 2024 Apr 22:ijgc-2024-005336. PubMedAbstract available
ROSATI A, Certelli C, Ferrandina G, Fanfani F, et al Minimally invasive adrenalectomy: a personalized surgical approach in recurrent
cervical cancer.
Int J Gynecol Cancer. 2024 Apr 22:ijgc-2023-005241. PubMed
KOHLER C, Plaikner A, Siegler K, Hertel H, et al Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in
patients with early cervical cancer.
Int J Gynecol Cancer. 2024 Apr 10:ijgc-2024-005274. PubMedAbstract available
HANEY K, Ismail-Pratt I, Ng JS, Schmeler KM, et al The International Gynecologic Cancer Society Preinvasive Certificate Program:
building a skilled workforce for the detection and treatment of cervical
pre-cancer.
Int J Gynecol Cancer. 2024;34:637-638. PubMed
KEMAH BL, Bhagat N, Pandya A, Sullivan R, et al Training the gynecologic oncologists of the future - challenges and
opportunities.
Int J Gynecol Cancer. 2024;34:619-626. PubMedAbstract available
March 2024
WESS B, Kohler C, Plaikner A, El-Safadi S, et al Comparative study using indocyanine green and patent blue dye for sentinel lymph
node biopsy in patients with early-stage cervical cancer.
Int J Gynecol Cancer. 2024 Mar 14:ijgc-2023-005206. PubMedAbstract available
DEL M, Illac C, Morisseau M, Angeles MA, et al Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread
of locally advanced cervical cancer.
Int J Gynecol Cancer. 2024 Mar 12:ijgc-2023-004677. PubMedAbstract available
JAYRAJ AS, Singhal S The beginning of the end for cervical cancer in India.
Int J Gynecol Cancer. 2024 Mar 7:ijgc-2024-005420. doi: 10.1136/ijgc-2024-005420 PubMed
VIVEROS-CARRENO D, Pareja R, Plante M De-escalation of surgical radicality for non-fertility preserving management in
patients with early-stage cervical cancer: a systematic review.
Int J Gynecol Cancer. 2024;34:386-392. PubMedAbstract available
PETERS I, Marchetti C, Scambia G, Fagotti A, et al New windows of surgical opportunity for gynecological cancers in the era of
targeted therapies.
Int J Gynecol Cancer. 2024;34:352-362. PubMedAbstract available
February 2024
FOTOPOULOU C, Eriksson AG, Planchamp F, Morice P, et al European Society of Gynaecological Oncology expanded quality indicators and
accreditation for cervical cancer management.
Int J Gynecol Cancer. 2024 Feb 23:ijgc-2024-005293. PubMed
BIZZARRI N, Obermair A, Hsu HC, Chacon E, et al Consensus on surgical technique for sentinel lymph node dissection in cervical
cancer.
Int J Gynecol Cancer. 2024 Feb 20:ijgc-2023-005151. PubMedAbstract available
VAZQUEZ-VICENTE D, Boria F, Castellanos T, Gutierrez M, et al SUCCOR morbidity: complications in minimally invasive versus open radical
hysterectomy in early cervical cancer.
Int J Gynecol Cancer. 2024;34:203-208. PubMedAbstract available
DELLINO M, Cerbone M, Fortunato F, Capursi T, et al Incidence of pre-neoplastic and neoplastic lesions of the cervix before and after
the COVID-19 pandemic.
Int J Gynecol Cancer. 2024;34:224-228. PubMedAbstract available
KHURANA N, Frumovitz M, Flores Legarreta A, Ramalingam P, et al Impact of pelvic radiation therapy in patients with early neuroendocrine cervical
carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR
study.
Int J Gynecol Cancer. 2024;34:209-215. PubMedAbstract available
DOSTALEK L, Freitag P, Slovackova M, Zima T, et al HPV testing as an effective triage strategy in the follow-up after
fertility-sparing treatment for glandular lesions of the uterine cervix.
Int J Gynecol Cancer. 2024;34:216-223. PubMedAbstract available
January 2024
LAAN J, van Lonkhuijzen L, Hinnen K, Pieters B, et al Malnutrition is associated with poor survival in women receiving radiotherapy for
cervical cancer.
Int J Gynecol Cancer. 2024 Jan 17:ijgc-2023-005024. PubMedAbstract available
KANG WD, Ju UC, Kim SM Human papillomavirus genotyping for predicting disease progression in women with
biopsy-negative or cervical intraepithelial neoplasia grade 1 of low-grade
intraepithelial lesion cytology.
Int J Gynecol Cancer. 2024;34:12-18. PubMedAbstract available
FITCH K, Bohn JA, Emerson JB, Boniface ER, et al Acceptability of human papillomavirus self-collection and the role of telehealth:
a prospective, randomized study stratified by menopausal status.
Int J Gynecol Cancer. 2024;34:19-27. PubMedAbstract available
FERNANDEZ MA, Clark HD, Iniesta MD, Munsell MF, et al Sentinel lymph node mapping with indocyanine green using SPY-PHI in open radical
hysterectomy or trachelectomy.
Int J Gynecol Cancer. 2024;34:28-34. PubMedAbstract available
December 2023
RIBEIRO R, Baiocchi G, Moretti-Marques R, Linhares JC, et al Uterine transposition for fertility and ovarian function preservation after
radiotherapy.
Int J Gynecol Cancer. 2023;33:1837-1842. PubMedAbstract available
PARPINEL G, Laas-Faron E, Balaya V, Guani B, et al Survival after sentinel lymph node biopsy for early cervical cancers: a
systematic review and meta-analysis.
Int J Gynecol Cancer. 2023;33:1853-1860. PubMedAbstract available
PLAIKNER A, Siegler K, Kohler C Surgical steps of laparoscopic-assisted simple vaginal trachelectomy.
Int J Gynecol Cancer. 2023;33:1972-1973. PubMed
November 2023
BORGHI C, Biagioli E, Mauro J, Roberto A, et al Neoadjuvant chemotherapy prior to radical hysterectomy in locally advanced
cervical cancer: a systematic review and meta-analysis.
Int J Gynecol Cancer. 2023 Nov 27:ijgc-2023-004863. PubMedAbstract available
CARUSO G, Bruni S, Lapresa M, De Vitis LA, et al Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a
retrospective cohort study and systematic literature review.
Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004928. PubMedAbstract available
PARIDA P, Baburaj G, Rao M, Lewis S, et al Circulating cell-free DNA as a diagnostic and prognostic marker for cervical
cancer.
Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004873. PubMedAbstract available
KOUHEN F, El Ghanmi A Breaking the silence: the taboo surrounding HPV vaccination in Morocco.
Int J Gynecol Cancer. 2023;33:1835. PubMed
NITECKI R, Ramirez PT, Dundr P, Nemejcova K, et al MILACC study: could undetected lymph node micrometastases have impacted
recurrence rate in the LACC trial?
Int J Gynecol Cancer. 2023;33:1684-1689. PubMedAbstract available
ALLANSON ER, Burling M, Simcock B, Nicklin J, et al The Australian Society of Gynaecological Oncology Western Pacific Liaison group.
Int J Gynecol Cancer. 2023;33:1819-1820. PubMed
October 2023
SALCEDO MP, Lathrop E, Osman N, Neves A, et al The Mulher Study: cervical cancer screening with primary HPV testing in
Mozambique.
Int J Gynecol Cancer. 2023 Oct 31:ijgc-2023-004958. PubMedAbstract available
XIA L, Wang J, Wang C, Zhang Q, et al Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with
recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II
study.
Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004705. PubMedAbstract available
FRUMOVITZ M, Morani AC, Aziz A, Jhingran A, et al PET/CT scan improves detection of metastatic disease compared with CT scan alone
in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.
Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004907. PubMedAbstract available
MBURU A, Shaffi AF Pathological pelvic fracture due to metastatic cervical cancer in a young
immunosuppressed woman.
Int J Gynecol Cancer. 2023 Oct 19:ijgc-2023-004479. PubMed
September 2023
BIZZARRI N, Russo L, Dolciami M, Zormpas-Petridis K, et al Radiomics systematic review in cervical cancer: gynecological oncologists'
perspective.
Int J Gynecol Cancer. 2023 Sep 15:ijgc-2023-004589. PubMedAbstract available
PLAIKNER A, Siegler K, Hertel H, Jacob A, et al Fertility sparing therapy in women with lymph node negative cervical cancer >2cm
- oncologic and fertility outcomes of neoadjuvant chemotherapy followed by
radical vaginal trachelectomy.
Int J Gynecol Cancer. 2023 Sep 11:ijgc-2023-004669. PubMedAbstract available
TURCO LC, Pedone Anchora L, Scambia G, Ferrandina G, et al Response to: Correspondence on "Human papillomavirus independent status on
pathologic response and outcomes in locally advanced cervical cancer managed with
chemoradiotherapy followed by surgery" by Yuce Sari et al.
Int J Gynecol Cancer. 2023;33:1491-1492. PubMed
YUCE SARI S, Bay M, Gultekin M Correspondence on 'Human papillomavirus independent status on pathologic response
and outcomes in locally advanced cervical cancer managed with chemoradiotherapy
followed by surgery' by Turco et al.
Int J Gynecol Cancer. 2023;33:1490. PubMed
NAKISIGE C, de Fouw M, Kabukye J, Sultanov M, et al Artificial intelligence and visual inspection in cervical cancer screening.
Int J Gynecol Cancer. 2023 Sep 4:ijgc-2023-004397. doi: 10.1136/ijgc-2023-004397 PubMedAbstract available
SALVO G, Flores Legarreta A, Ramalingam P, Jhingran A, et al Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in
neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry
study.
Int J Gynecol Cancer. 2023;33:1359-1369. PubMedAbstract available
MICHAAN N, Wenkert A, Even-Sapir E, Kerzhner K, et al Prognostic significance of delayed complete metabolic response on PET/CT after
primary chemoradiation treatment of cervical cancer.
Int J Gynecol Cancer. 2023 Sep 1:ijgc-2023-004703. doi: 10.1136/ijgc-2023-004703 PubMedAbstract available
August 2023
MAURO J, Viveros-Carreno D, Vizzielli G, De Ponti E, et al Survival after sentinel node biopsy alone in early-stage cervical cancer: a
systematic review.
Int J Gynecol Cancer. 2023 Aug 16:ijgc-2023-004692. PubMedAbstract available
GONZALEZ-OCHOA E, Milosevic M, Corr B, Abbruzzese JL, et al A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination
with chemoradiation in cervical, upper vaginal, and uterine cancers.
Int J Gynecol Cancer. 2023;33:1208-1214. PubMedAbstract available
July 2023
BOGANI G, Ghelardi A, Sopracordevole F, Annoni M, et al Human papillomavirus (HPV) vaccination: a call for action in Italy.
Int J Gynecol Cancer. 2023;33:1132-1139. PubMedAbstract available
June 2023
OBERMAIR A, Leitao M Correspondence on "ESGO/ESTRO/ESP guidelines fpr the management of patients with
cervical cancer: update 2023" by Cibula et al.
Int J Gynecol Cancer. 2023 Jun 15:ijgc-2023-004645. PubMed
PAREJA R, Heredia F, Leitao M Correspondence on 'ESGO/ESTRO/ESP Guidelines for the management of patients with
cervical cancer - Update 2023*'.
Int J Gynecol Cancer. 2023 Jun 9:ijgc-2023-004656. doi: 10.1136/ijgc-2023-004656 PubMed
KOBAYASHI E, Takekuma M, Enomoto T, Okamoto A, et al Response to: Commentary on "Surgical skill and oncological outcome of
laparoscopic radical hysterectomy: JGOG1081S-A1, an ancillary analysis of the
Japanese Gynecologic Oncology Group Study JGOG1081" by Ramirez et al.
Int J Gynecol Cancer. 2023;33:1012. PubMed
CORDOBA A, El Hajj H, Martinez-Gomez C, Hudry D, et al Should the cut-off for concomitant radiochemotherapy and intracavitary 3D
adaptive uterovaginal brachytherapy be 3 cm?
Int J Gynecol Cancer. 2023;33:1010-1011. PubMed
CASTILLO MH, Rodriguez R, Chavez C, Baltazar D, et al Control and management of gynecological cancer in Peru.
Int J Gynecol Cancer. 2023;33:995-996. PubMed
NGUYEN CGT, Phillips S, Chen A, Harrison R, et al Isolated tumor cells in a patient with early-stage cervical cancer.
Int J Gynecol Cancer. 2023 Jun 2:ijgc-2022-004115. doi: 10.1136/ijgc-2022-004115 PubMed
May 2023
CHARGARI C, Tanderup K, Planchamp F, Chiva L, et al ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
Int J Gynecol Cancer. 2023 May 31:ijgc-2022-004180. PubMedAbstract available
ZHANG X, Wang Y, Lv X, Wang F, et al Intratumoral injection of oncolytic virus (H101) in combination with concurrent
chemoradiotherapy for locally advanced cervical cancer.
Int J Gynecol Cancer. 2023 May 19:ijgc-2022-003914. PubMedAbstract available
VIVEROS-CARRENO D, Vieira-Serna S, Grillo-Ardila CF, Rodriguez J, et al Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB
cervical cancer: a systematic review.
Int J Gynecol Cancer. 2023 May 16:ijgc-2023-004465. PubMedAbstract available
CIBULA D, Raspollini MR, Planchamp F, Centeno C, et al ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer -
Update 2023.
Int J Gynecol Cancer. 2023;33:649-666. PubMedAbstract available
ISHIKAWA M, Shibata T, Kataoka T, Takekuma M, et al Final analysis of a randomized phase II/III trial of conventional paclitaxel and
carboplatin with or without bevacizumab versus dose-dense paclitaxel and
carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent
cervical carcinom
Int J Gynecol Cancer. 2023;33:692-700. PubMedAbstract available
PELEG HASSON S, Felder S, Helpman L, Taylor A, et al Outcomes associated with treatment to all sites of disease in patients with stage
IVB cancer of the cervix.
Int J Gynecol Cancer. 2023;33:683-691. PubMedAbstract available
CUSCHIERI K, Fellner MD, Arroyo Muhr LS, Padalko E, et al Quality assurance in human papillomavirus testing for primary cervical screening.
Int J Gynecol Cancer. 2023;33:802-811. PubMedAbstract available
LEVYTSKA K, Pena SR, Brown J, Yu Z, et al Opioid and benzodiazepine use in gynecologic oncology patients.
Int J Gynecol Cancer. 2023;33:786-791. PubMedAbstract available
April 2023
BUDA A, Fanfani F The patterns of growth of cervical cancer: a challenge to personalized radical
surgery.
Int J Gynecol Cancer. 2023 Apr 25:ijgc-2023-004556. PubMed
RAMIREZ PT ESGO/ESTRO/ESP updated guidelines in cervical cancer.
Int J Gynecol Cancer. 2023 Apr 13:ijgc-2023-004523. PubMed
SAGAE S, Toita T, Matsuura M, Saito M, et al Improvement in radiation techniques for locally advanced cervical cancer during
the last two decades.
Int J Gynecol Cancer. 2023 Apr 11:ijgc-2022-004230. PubMedAbstract available
TOUHAMI O, Plante M, St-Gelais J, Frumovitz M, et al Association of nivolumab and niraparib in the management of neuroendocrine cancer
of the cervix.
Int J Gynecol Cancer. 2023;33:623-627. PubMed
KESIC V, Carcopino X, Preti M, Vieira-Baptista P, et al The European Society of Gynaecological Oncology (ESGO), the International Society
for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study
of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC)
consensus s
Int J Gynecol Cancer. 2023;33:446-461. PubMedAbstract available
KAMANI MO, Kyrgiou M, Joura E, Zapardiel I, et al ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
Int J Gynecol Cancer. 2023;33:462-464. PubMed
GOMEZ CHEREY JF, Payalef SN, Fleider L, Reyes AP, et al Microbiota unbalance in relation to high-risk human papillomavirus cervical
infection.
Int J Gynecol Cancer. 2023;33:482-488. PubMedAbstract available
BOCCIOLONE L, Candotti G, Cioffi R, Rabaiotti E, et al Sentinel lymph node biopsy in open surgery for gynecological malignancies.
Int J Gynecol Cancer. 2023;33:636-637. PubMed
March 2023
SOOCHIT A, Zhang C, Feng Y, Luo X, et al Impact of different post-operative treatment modalities on long-term outcomes in
International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp
cervical cancer.
Int J Gynecol Cancer. 2023 Mar 31:ijgc-2022-004234. PubMedAbstract available
CAPOZZI VA, Rotondella I, De Finis A, Scarpelli E, et al Rectovaginal fistula repair by Martius flap after exclusive chemoradiation in a
patient with advanced cervical cancer.
Int J Gynecol Cancer. 2023 Mar 23:ijgc-2023-004365. PubMed
OBERMAIR A, Pareja R Can simple hysterectomy replace radical hysterectomy as treatment of early-stage
cervical cancer?
Int J Gynecol Cancer. 2023 Mar 10:ijgc-2023-004372. PubMed
VIVEROS-CARRENO D, Fernandes A, Pareja R Updates on cervical cancer prevention.
Int J Gynecol Cancer. 2023;33:394-402. PubMedAbstract available
GRAU JF, Farinas-Madrid L, Garcia-Duran C, Garcia-Illescas D, et al Advances in immunotherapy in cervical cancer.
Int J Gynecol Cancer. 2023;33:403-413. PubMedAbstract available
CHELARIU-RAICU A, Mahner S, Moore KN, Lorusso D, et al Integrating antibody drug conjugates in the management of gynecologic cancers.
Int J Gynecol Cancer. 2023;33:420-429. PubMedAbstract available